Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
24,695,954
-
Share change
-
-4,772,092
-
Total reported value
-
$13,342,110
-
Price per share
-
$0.53
-
Number of holders
-
52
-
Value change
-
-$2,100,368
-
Number of buys
-
23
-
Number of sells
-
51
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2025
As of 30 Jun 2025,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,695,954 shares.
The largest 10 holders included
Caligan Partners LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Sovran Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, Mariner, LLC, NORTHERN TRUST CORP, Y-Intercept (Hong Kong) Ltd, and GOLDMAN SACHS GROUP INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.